Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 5Neoplasms 3Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Ovarian Cysts 1Myofibroma 1Lung Neoplasms 1Liver Neoplasms 1Hematologic Diseases 1Endobronchial Metastases 1Encephalocele 1Ear Neoplasms 1Cholecystitis 1Breast Neoplasms 1Brain Injuries 1

Interventions

Saline Solution 3Ropivacaine 2Propofol 2Morphine 2Mannitol 2Dexmedetomidine 2lonafarnib 1dexketoprofen trometamol 1Temozolomide 1Stem Cell Transplantation 1Remifentanil 1Long-Term Synaptic Depression 1Lidocaine 1HES 130-0.4 1Epinephrine 1Dexamethasone 1Desflurane 1Bupivacaine 1Analgesics, Opioid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Supratentorial Neoplasms × Remifentanil × Clear all
NCT02593942 2015-11-02

Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy

Yeditepe University Hospital

Phase 4 Completed
80 enrolled

Supratentorial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡